Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared a Form S-3 filed by HOOKIPA Pharma Inc. effective as of January 4, 2024, at 4:01 P.M. This form is a registration statement that allows companies to issue various types of securities. The effectiveness of this form indicates that HOOKIPA Pharma has met all the necessary regulatory requirements to potentially offer securities to the public.